In the News.. Arthritis drug studied for T1D, calls to poison control over Ozempic, Tandem Source released, and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: an existing drug for arthritis is being studied for treatment of T1D, poison control centers report a big increase in calls about misdosing of Ozmepic and semaglutides, Tandem releases it’s Tandem Source software,…